Periodic Reporting for period 1 - Biomarkers for PD (Validation of diagnostic and prognostic biomarkers for Parkinson disease)
Período documentado: 2015-09-01 hasta 2016-02-29
In this project we have:
• Acquired Human CSF from patients with Parkinson’s disease and healthy controls
• Conducted Biochemical biomarker assay development for Parkinson’s disease
• Conducted a pilot study on clinical cohorts including patients with Parkinson’s disease and healthy controls
• Evaluated the business opportunities and further development path for Parkinson’s disease biomarkers
Market research in the form of in depth interviews with KOL’s have confirmed the most important potential customer, business opportunities, barriers and commercial value for a new biochemical biomarker in Parkinson’s disease.